Life ScienceCompany
AstraZeneca M&A Summary
AstraZeneca has acquired 24 companies, including 11 in the last 5 years. A total of 6 acquisitions came from private equity firms. It has also divested 11 assets.
AstraZeneca’s largest acquisition to date was in 2020, when it acquired Alexion Pharmaceuticals for $39.0B. It’s largest disclosed sale occurred in 2016, when it sold AstraZeneca - Small Molecule Anti-Infective Business to Pfizer for $550M. AstraZeneca has acquired in 8 different US states, and 9 countries. The Company’s most targeted sectors include life science (91%) and medical products (5%).
AstraZeneca Business Overview
Where is AstraZeneca headquartered?
AstraZeneca is headquartered in Cambridge, United Kingdom.
What is AstraZeneca’s revenue?
AstraZeneca disclosed revenue of 54,073M USD for 2024 and 45,811M USD for 2023.
How many employees does AstraZeneca have?
AstraZeneca has 83,100 employees.
What sector is AstraZeneca in?
AstraZeneca is a life science company.
When was AstraZeneca founded?
AstraZeneca was founded in 1992.
M&A Summary
-
M&A Total Activity33
- M&A Buy Activity22
- M&A Sell Activity11
- Total Sectors Invested 3
- Total Countries Invested 9
- M&A Buy/Sell Connections 21
- M&A Advisors 4
Unlimited Searches
